Trial Profile
Sex and Disease Dependent Nucleoside Analog Toxicity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Mar 2020
Price :
$35
*
At a glance
- Drugs Lamivudine/zidovudine (Primary)
- Indications HIV infections
- Focus Pharmacogenomic; Pharmacokinetics
- 05 Jul 2011 New trial record